國立高雄大學圖資館 |

語系: 繁體中文

說明(常見問題)

圖資館首頁

登入

回首頁 到查詢結果 [ subject:"Drug-Related Side Effects and Adverse Reactions." ]

切換: 標籤 | MARC模式 | ISBD

Personalized cancer chemotherapyan e...

Lu, Da-Yong, (1962-)

Personalized cancer chemotherapyan effective way of enhancing outcomes in clinics /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Personalized cancer chemotherapyDa-Yong Lu.
其他題名:	an effective way of enhancing outcomes in clinics /
作者:	Lu, Da-Yong,
出版者:	Cambridge, UK :Elsevier/Woodhead Publishing,©2015.
面頁冊數:	1 online resource (85 p.) :ill. (some col.).
標題:	Chemotherapy.
電子資源:	https://www.sciencedirect.com/science/book/9780081003466
ISBN:	9780081003473 (electronic bk.)

Personalized cancer chemotherapyan effective way of enhancing outcomes in clinics /
Lu, Da-Yong,1962-

Personalized cancer chemotherapyan effective way of enhancing outcomes in clinics /[electronic resource] :Da-Yong Lu. - Cambridge, UK :Elsevier/Woodhead Publishing,©2015. - 1 online resource (85 p.) :ill. (some col.). - Woodhead Publishing series in biomedicine,7202050-0289 ;. - Woodhead Publishing series in biomedicine ;no. 9..

Includes bibliographical references.

Introduction -- Drug sensitivity testing -- Individualized cancer chemotherapy via cancer biomarkers or bioinformatics detection -- Pharmacogenetics -- Individualized antimetastatic therapy [1-2] -- Drug combinations -- Assistant chemotherapy -- Cost-effectiveness considerations -- Discussion -- Conclusion.

Individualized cancer chemotherapy (ICC) has been designed to meet the requirement of selecting anticancer drugs in clinics and attracting increasing attentions in medical circle and will show more beneficial outcome in the future if we stick on these researches. Personalized Cancer Chemotherapy addresses and reviews this issue by discussing many existing specific strategies of ICC, including drug sensitivity testing, cancer biomarker detections, cancer biomarker-oriented therapy, anticancer drug pharmacogenetics, cancer metastasis therapy, anticancer drug combinations, assistant therapy, mathematics, and computational analysis of cancer malignancy and drug responses, cost effective and finally studies of relationship between different ICC strategies. The relationship between drug response and these techniques or methods is in-depth analyzed, discussed and highlight. Many longstanding key debates and future trends are also intensively discussed, highlighted and debuted with new twists.

ISBN: 9780081003473 (electronic bk.)

LCCN: 2014957608Subjects--Topical Terms:

218143
Chemotherapy.
Index Terms--Genre/Form:

214472
Electronic books.

LC Class. No.: RM263

Dewey Class. No.: 616.99406

National Library of Medicine Call No.: QZ 267

Personalized cancer chemotherapyan effective way of enhancing outcomes in clinics /
LDR:02693nmm a2200313 a 4500 001 578377
006 m o d
007 cr |||||||||||
008 201211s2015 enka ob 000 0 eng d
010 $a 2014957608
020 $a 9780081003473 (electronic bk.)
020 $a 0081003471 (electronic bk.)
020 $a 9780081003466 (print)
020 $a 0081003463 (print)
035 $a (OCoLC)898423398
035 $a ELS20100011
040 $a EBLCP $b eng $c EBLCP $d N $d OCLCQ $d YDXCP $d OPELS $d OCLCF $d MMU $d OCLCO $d CHVBK $d OCLCQ $d CNCGM $d OCLCO $d MERER $d OCLCO $d OCLCQ $d OCLCA $d U3W $d OCLCO $d D6H $d OCLCQ $d AU@ $d OCLCO $d OCLCQ $d WYU $d CUY $d LOA $d ZCU $d USU $d MERUC $d OCLCO $d ICG $d K6U $d COCUF $d OCLCQ $d VT2 $d DKC $d FEM $d IDEBK $d CDX $d OCLCO $d OCLCQ $d OCLCO $d OCLCQ $d OCLCA $d OCLCQ $d OCLCA
041 0 $a eng
050 4 $a RM263
060 4 $a QZ 267
082 0 4 $a 616.99406 $2 23
100 1 $a Lu, Da-Yong, $d 1962- $e author. $3 867121
245 1 0 $a Personalized cancer chemotherapy $h [electronic resource] : $b an effective way of enhancing outcomes in clinics / $c Da-Yong Lu.
260 $a Cambridge, UK : $b Elsevier/Woodhead Publishing, $c ©2015.
300 $a 1 online resource (85 p.) : $b ill. (some col.).
490 1 $a Woodhead Publishing series in biomedicine, $x 2050-0289 ; $v 720
504 $a Includes bibliographical references.
505 0 $a Introduction -- Drug sensitivity testing -- Individualized cancer chemotherapy via cancer biomarkers or bioinformatics detection -- Pharmacogenetics -- Individualized antimetastatic therapy [1-2] -- Drug combinations -- Assistant chemotherapy -- Cost-effectiveness considerations -- Discussion -- Conclusion.
520 $a Individualized cancer chemotherapy (ICC) has been designed to meet the requirement of selecting anticancer drugs in clinics and attracting increasing attentions in medical circle and will show more beneficial outcome in the future if we stick on these researches. Personalized Cancer Chemotherapy addresses and reviews this issue by discussing many existing specific strategies of ICC, including drug sensitivity testing, cancer biomarker detections, cancer biomarker-oriented therapy, anticancer drug pharmacogenetics, cancer metastasis therapy, anticancer drug combinations, assistant therapy, mathematics, and computational analysis of cancer malignancy and drug responses, cost effective and finally studies of relationship between different ICC strategies. The relationship between drug response and these techniques or methods is in-depth analyzed, discussed and highlight. Many longstanding key debates and future trends are also intensively discussed, highlighted and debuted with new twists.
588 0 $a Online resource; title from electronic title page (ebrary, viewed on April 3, 2015).).
650 0 $a Chemotherapy. $3 218143
650 0 $a Cancer $x Treatment. $3 252269
650 1 2 $a Neoplasms $x drug therapy. $3 345776
650 2 2 $a Antineoplastic Agents. $3 226661
650 2 2 $a Drug-Related Side Effects and Adverse Reactions. $3 667246
650 2 2 $a Pharmacogenetics $x methods. $3 229038
650 2 2 $a Precision Medicine $x methods. $3 845376
655 4 $a Electronic books. $2 local. $3 214472
830 0 $a Woodhead Publishing series in biomedicine ; $v no. 9. $3 619116
856 4 0 $u https://www.sciencedirect.com/science/book/9780081003466